Growth • Thermo Fisher Scientific
TMO
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
10,9%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
13%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
11,4%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
12,5%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
16,1%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
11,8%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!